icon-folder.gif   Conference Reports for NATAP  
 
  AASLD/EASL Special Conference
on Hepatitis C
New York City, New York
September 12 - 13
Back grey_arrow_rt.gif
 
 
 
Preclinical Characterization of AL-335, a Potent Uridine Based Nucleoside Polymerase Inhibitor for the Treatment of Chronic Hepatitis C
 
 
  Reported by Jules Levin
AASLD/EASL NY HCV Conference, Sept 12-13 2014
 
Hua Tan, Kenneth Shaw, Andreas Jekle, Jerome Deval, Zhinan Jin, Amy Fung, Yuen Tam, Lawrence M. Blatt, Sushmita M. Chanda, Guangyi Wang, Natalia Dyatkina, Marija Prhavc, Caroline Williams, Vlad Serebryany, Qingling Zhang, Julian A. Symons, Leonid Beigelman and David B. Smith*
 
Alios BioPharma, Inc., 260 E. Grand Avenue, South San Francisco, CA, USA.

IDSA1.gif

IDSA2.gif

IDSA3.gif

IDSA4.gif

IDSA5.gif